BlackRock Fund Advisors’s Stemline Therapeutics, Inc. STML Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $5.96M | Buy |
556,567
+85,512
| +18% | +$915K | ﹤0.01% | 2850 |
|
|
2016
Q3 | $5.1M | Buy |
471,055
+33,039
| +8% | +$358K | ﹤0.01% | 2834 |
|
|
2016
Q2 | $2.97M | Buy |
438,016
+31,748
| +8% | +$215K | ﹤0.01% | 3078 |
|
|
2016
Q1 | $1.89M | Buy |
406,268
+1,724
| +0.4% | +$8.03K | ﹤0.01% | 3093 |
|
|
2015
Q4 | $2.55M | Buy |
404,544
+12,719
| +3% | +$80.3K | ﹤0.01% | 3090 |
|
|
2015
Q3 | $3.46M | Sell |
391,825
-4,692
| -1% | -$41.4K | ﹤0.01% | 2970 |
|
|
2015
Q2 | $4.67M | Sell |
396,517
-15,726
| -4% | -$185K | ﹤0.01% | 2964 |
|
|
2015
Q1 | $5.97M | Buy |
412,243
+82,989
| +25% | +$1.2M | ﹤0.01% | 2742 |
|
|
2014
Q4 | $5.62M | Buy |
329,254
+55,556
| +20% | +$948K | ﹤0.01% | 2808 |
|
|
2014
Q3 | $3.41M | Sell |
273,698
-11,411
| -4% | -$142K | ﹤0.01% | 2964 |
|
|
2014
Q2 | $4.18M | Buy |
285,109
+13,388
| +5% | +$196K | ﹤0.01% | 2935 |
|
|
2014
Q1 | $5.53M | Buy |
271,721
+9,008
| +3% | +$183K | ﹤0.01% | 2764 |
|
|
2013
Q4 | $5.15M | Buy |
262,713
+3,091
| +1% | +$60.6K | ﹤0.01% | 2811 |
|
|
2013
Q3 | $11.8M | Buy |
259,622
+30,529
| +13% | +$1.38M | ﹤0.01% | 2259 |
|
|
2013
Q2 | $5.46M | Buy |
+229,093
| New | +$5.46M | ﹤0.01% | 2630 |
|